Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.420
-0.050 (-3.40%)
At close: Jun 2, 2026, 4:00 PM EDT
1.420
0.00 (0.00%)
Pre-market: Jun 3, 2026, 5:59 AM EDT
Traws Pharma Employees
As of December 31, 2025, Traws Pharma had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$390,429
Profits / Employee
-$1,987,143
Market Cap
21.51M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | 0 | - | 4 | 3 |
| Dec 31, 2024 | 7 | -11 | -61.11% | 6 | 1 |
| Dec 31, 2023 | 18 | 1 | 5.88% | 17 | 1 |
| Dec 31, 2022 | 17 | 2 | 13.33% | 16 | 1 |
| Dec 31, 2021 | 15 | 3 | 25.00% | 14 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Werewolf Therapeutics | 39 |
| Longeveron | 38 |
| Curis | 24 |
| Cellectar Biosciences | 11 |
| VYNE Therapeutics | 10 |
| Exicure | 8 |
| AEON Biopharma | 8 |
| Pasithea Therapeutics | 5 |
TRAW News
- 4 days ago - Traws Pharma Proxy statement: Proxy filing - Filings
- 4 days ago - Traws Pharma Proxy statement: Proxy filing - Filings
- 6 days ago - Traws Pharma announces antiviral program targeting Hantavirus, Ebola - TheFly
- 6 days ago - Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks - GlobeNewsWire
- 14 days ago - Traws Pharma Proxy statement: Proxy filing - Filings
- 18 days ago - Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results - GlobeNewsWire
- 18 days ago - Traws Pharma Quarterly report: Q1 2026 - Filings
- 18 days ago - Traws Pharma Earnings release: Q1 2026 - Filings